WeiBM, FoxLP, KaffenbergerBH, et al.Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis. J Am Acad Dermatol. 2024; 90(5):885–908; doi: 10.1016/j.jaad.2023.02.072
2.
GrootAC. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review. Contact Dermatitis. 2022; 86:443–479; doi: 10.1111/cod.14090
3.
KardaunSH, SekulaP, Valeyrie-AllanoreL, et al.Drug reaction with eosinophilia and systemic symptoms (DRESS): An original multisystem adverse drug reaction. Results from the prospective RegiSCAR study. Br J Dermatol. 2013; 169(5):1071–1080; doi: 10.1111/bjd.12501
4.
Queensland Health, Q. (2021). Management of tuberculosis in pregnant women and newborn infants—Guideline, Version 3.2 - November 2021. 2021.
5.
WoodruffCM, BottoN. The role of patch testing in evaluating delayed hypersensitivity reactions to medications. Clin Rev Allergy Immunol. 2022; 62(3):548–561; doi: 10.1007/s12016-022-08924-2
